{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/6723bd290e172486e44bd6e7/68121185f3c711a5d0040bf7?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Ozempic vs Mounjaro - Investing in Pharmaceuticals","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/6723bd290e172486e44bd6e7/1746014566596-e69a8d00-7a7e-4212-84d8-05ed2ab44dee.jpeg?height=200","description":"<p>Ozempic (NVO) and Mounjaro (LLY) are dominating headlines due to radical obesity medication — but what does that mean for traders and investors? We analyse the pharmaceutical market potential and blockbuster future drugs. Plus: Trump tariff u-turns. What traders need to know.</p>","author_name":"Hugo Ward"}